Jörg Ogorka

Title: Jörg Ogorka: Innovator in Pharmaceutical Dosage Forms

Introduction

Jörg Ogorka is a notable inventor based in Steinen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on enhancing the efficacy and delivery of medications, which is crucial for patient care.

Latest Patents

Jörg Ogorka holds a patent for a melt-processed imatinib dosage form. This invention provides a dosage form that includes a melt-processed mixture of a pharmaceutically effective amount of imatinib or a salt thereof, at least one polymeric binder, and at least one pharmaceutically acceptable non-ionic surfactant. The patent highlights the advantages of high drug loading, simple and efficient preparation methods, and the ability to release the active principle in a pH-independent manner. Additionally, it offers extended release imatinib dosage forms, which can improve patient compliance and therapeutic outcomes.

Career Highlights

Throughout his career, Jörg Ogorka has worked with prominent companies in the pharmaceutical industry. He has been associated with AbbVie Deutschland GmbH & Co. KG and Novartis AG, where he has contributed to various projects aimed at improving drug formulations and delivery systems. His expertise in pharmaceutical sciences has made him a valuable asset in these organizations.

Collaborations

Jörg Ogorka has collaborated with several professionals in the field, including Jörg Breitenbach and Norbert Steiger. These collaborations have fostered innovation and have led to advancements in pharmaceutical technologies.

Conclusion

Jörg Ogorka's contributions to the field of pharmaceuticals, particularly through his patent on melt-processed imatinib dosage forms, demonstrate his commitment to improving medication delivery and patient care. His work continues to influence the industry and pave the way for future innovations.